SOX2 and neoplasm: Surprisingly, with the exception of one case of low level amplification documented in a score 3 primary tumor, unlike reported in other tumors, the majority of analyzed samples did not show SOX2 gene amplifications, suggesting that at least in part of the breast carcinomas expressing SOX2, the aberrant gene expression is driven by other mechanisms.